Dr Reddys

Showing of 1 - 20 from 57 results
Dr Reddys - Total results - 57
DCGI approves Dr Reddy's request to conduct Phase 2, 3 clinical trials with Russia's Sputnik V COVD-19 vaccine
science

DCGI approves Dr Reddy's request to conduct Phase 2, 3 clinical trials with Russia's Sputnik V COVD-19 vaccine

RDIF will also supply 100 million doses of Dr Reddy's after receiving Indian regulatory approval.

COVID-19 recoveries continue to surpass new cases; next two-and-a-half month period crucial says Harsh Vardhan
India

COVID-19 recoveries continue to surpass new cases; next two-and-a-half month period crucial says Harsh Vardhan

The health ministry also said on Friday that India has one of the lowest COVID-19 deaths per million population in the world, with less than 1,000 fatalities registered daily since 4 October,

Dr Reddy's asked to resubmit phase 2,3 trial application for Russia's Sputnik V COVID-19 vaccine by DCGI
India

Dr Reddy's asked to resubmit phase 2,3 trial application for Russia's Sputnik V COVID-19 vaccine by DCGI

Dr Reddy's trials will have to be first assessed in a small group of volunteers to study its efficacy before it can be tested on a larger population.

RDIF, Dr Reddy's Lab tie up for Sputnik V human trials, distribution of 100 mn doses of the COVID-19 vaccine in India
India

RDIF, Dr Reddy's Lab tie up for Sputnik V human trials, distribution of 100 mn doses of the COVID-19 vaccine in India

As of 1 August, Phase I and II of the vaccine were complete and by 11 August, Russian President Vladimir Putin had registered it as the world's first vaccine.

India's COVID-19 tally surpasses 50 lakh with 90,123 new cases: AstraZeneca trials to resume
India

India's COVID-19 tally surpasses 50 lakh with 90,123 new cases: AstraZeneca trials to resume

The Serum Institute of India, which had paused phase 2 and phase 3 trials of the Oxford University's vaccine, received the go-ahead from the DCGI to resume the trials in India

Coronavirus Updates: Maharashtra reports 14,492 new COVID-19 cases, 326 deaths; tally rises to 6,43,289
India

Coronavirus Updates: Maharashtra reports 14,492 new COVID-19 cases, 326 deaths; tally rises to 6,43,289

Coronavirus LIVE Updates: As many as 26 volunteers who reached the Air-India Express plane crash site in Kozhikode evacuated the injured passengers on 7 August, have tested positive for COVID-19

Govt's unlock Phase 1.0 enthuses markets: Sensex soars 879 points, Nifty jumps to 9,800-level; Bajaj Finance top gainer at around 11%
Business

Govt's unlock Phase 1.0 enthuses markets: Sensex soars 879 points, Nifty jumps to 9,800-level; Bajaj Finance top gainer at around 11%

The Sensex surged driven by gains in Reliance Industries, HDFC twins and TCS as investor optimism heightened after the government began the process of unlocking the economy.

Dr Reddy's Q4 profit jumps 76% to Rs 764 cr on higher sales in US, Europe; revenue up 10% at Rs 4,432 cr
Business

Dr Reddy's Q4 profit jumps 76% to Rs 764 cr on higher sales in US, Europe; revenue up 10% at Rs 4,432 cr

Dr Reddy's said various initiatives have been undertaken to ensure that our manufacturing-related operations continue unabated enabling it to serve the patients.

Dr Reddy's Labs to acquire branded generics business of Wockhardt for Rs 1,850 cr; deal to help scale-up presence in home market
Business

Dr Reddy's Labs to acquire branded generics business of Wockhardt for Rs 1,850 cr; deal to help scale-up presence in home market

Dr Reddy's will acquire select divisions of its branded generics business in India and a few other international territories of Nepal, Sri Lanka, Bhutan and Maldives.

India pharma majors Dr Reddy's, Wockhardt, and others deny allegations of conspiracy to fix prices in US
Business

India pharma majors Dr Reddy's, Wockhardt, and others deny allegations of conspiracy to fix prices in US

The generic drug makers are named in an anti-trust lawsuit in the US on allegations of engaging in a conspiracy to fix prices

Stock markets expected to perform better in 2019; here are 10 stocks that could give good returns in 2019
Business

Stock markets expected to perform better in 2019; here are 10 stocks that could give good returns in 2019

We believe the markets will be likely in a consolidation mode going forward with some correction that can bring down the valuations to a cheaper level. Risk aversion will be the flavor

Pharma sector may post 17% revenue growth in June quarter; domestic growth, currency tailwinds to drive growth: Report
Business

Pharma sector may post 17% revenue growth in June quarter; domestic growth, currency tailwinds to drive growth: Report

The domestic pharmaceutical sector accounts for 3.1-3.6 percent of the global pharmaceutical industry in value terms and 10 percent in volume terms.

Sensex down 102 points in cautious trade, slips below 35,000 mark; power, banking, realty stocks decline; Re dips
Business

Sensex down 102 points in cautious trade, slips below 35,000 mark; power, banking, realty stocks decline; Re dips

Sensex, which had lost 310.49 points in the previous two sessions, fell further by 101.70 points, or 0.29 percent, to 34,910.19.

Sensex slides 214 points on global cues, Nifty cracks below 10,600 mark; auto, bank stocks major losers
Business

Sensex slides 214 points on global cues, Nifty cracks below 10,600 mark; auto, bank stocks major losers

The 30-share index, which had lost 216.24 points in the previous session, drifted down by 214.13 points, or 0.61 percent, to 34,735.11.

Sensex opens higher over 53 points despite weak macro data ahead of Karnataka Assembly poll results; Re gains 12 paise
Business

Sensex opens higher over 53 points despite weak macro data ahead of Karnataka Assembly poll results; Re gains 12 paise

Sensex which had gained 289.52 points in the previous session, was trading higher by 53.21 points, or 0.14 percent, at 35,589, with realty, oil and gas, healthcare, PSU, banking and capital goods stocks leading the gains.

Sensex near 34,000 in early trade, up 107 points; PNB bounces back after recent slump
Business

Sensex near 34,000 in early trade, up 107 points; PNB bounces back after recent slump

Stocks of Punjab National Bank which had been under selling pressure since the massive fraud detection, however, edged 1.05 percent higher.

Nifty crosses 10,600 mark for the first time, while Sensex soars to 34,331; pharma, IT, banking stocks gain
Business

Nifty crosses 10,600 mark for the first time, while Sensex soars to 34,331; pharma, IT, banking stocks gain

The 30-share Sensex soared by 178 points, or 0.52 percent, to 34,331.85 points, breaching its previous record high (intra-day) of 34,188.85 hit on 5 January.

Sensex up 101 points to 33,895; rupee rises by 14 paise against dollar
Business

Sensex up 101 points to 33,895; rupee rises by 14 paise against dollar

The benchmark BSE Sensex was trading higher by 101.89 points or 0.30 percent at 33,895.27

Sensex sinks 260 points, Nifty ends below 10,000 as Sebi clamps down on shell companies
Business

Sensex sinks 260 points, Nifty ends below 10,000 as Sebi clamps down on shell companies

Among the sectoral indices, realty was the hardest hit, down 4.53 percent